5 Articles
5 Articles
The Spanish Agency for Medicines and Health Products (AEMPS) has received up to 2025 a total of 146 reports of suspected large-cell anaplastic lymphoma (LACG) associated with breast implants in Spain, 111 of which have been confirmed. According to the institution, the LACG associated with prosthesis is a rare type of non-Hodgkin lymphoma that affects a wide variety of tissues, including the breast, in people carrying prosthesis.
The AEMPS has confirmed 111 cases of LACG associated with breast implants in Spain. Discover the details of this rare lymphoma and how its relationship with prosthetics is being investigated. Read more LACG and breast implants: risks, diagnosis and follow-up in Spain in News.es.
The Spanish Agency for Medicines and Health Products (AEMPS) has received up to 2025 a total of 146 reports of suspected large cell anaplastic lymphoma (LACG) associated with breast implants in Spain, of which 111 have been confirmed.
The Spanish Agency for Medicines and Health Products (AEMPS) has received 146 reports of suspected cases, of which 111 have been confirmed, of anaplastic large cell lymphoma (LACG) associated with breast implants in Spain until 2025 and since 2012, when the first case was known. It is a rare type of non-Hodgkin lymphoma that affects a wide variety of tissues, including the breast, in people carrying breast implants. It has a greater relationship…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


